Quality by Design in Drug Substance Process Development
AIChE Annual Meeting
2017
2017 Annual Meeting
Pharmaceutical Discovery, Development and Manufacturing Forum
Oral
101E
Minneapolis Convention Center
Thursday, November 2, 2017 - 3:15pm to 5:45pm
Chair(s)
Yang, Y., The Dow Chemical Company
Co-chair(s)
Modernization of regulatory processes in the pharmaceutical industry has led to several innovative approaches to risk-based implementation of Quality by Design. Speakers for this session should include topics describing their application of QbD principles with examples of determination of critical process parameters (CPPs), mapping of design spaces (DS), real time process monitoring, and the determination of appropriate control strategies for small and large molecule drug substance processes.
Presentations
Topics
Checkout
Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.
Do you already own this?
Log In for instructions on accessing this content.
Pricing
Individuals
2017 Annual Meeting
| AIChE Pro Members | $150.00 |
| AIChE Graduate Student Members | Free |
| AIChE Undergraduate Student Members | Free |
| AIChE Explorer Members | $225.00 |
| Non-Members | $225.00 |
Pharmaceutical Discovery, Development and Manufacturing Forum only
| AIChE Pro Members | $100.00 |
| Food, Pharmaceutical & Bioengineering Division Members | Free |
| AIChE Graduate Student Members | Free |
| AIChE Undergraduate Student Members | Free |
| AIChE Explorer Members | $150.00 |
| Non-Members | $150.00 |